WebMay 1, 2009 · The multi-center set of trials include 12 clinical sites geographically distributed across the United States, a central laboratory, investigational drug service, cognitive function reading center, interactive voice response calling center and prostate biopsy reading center, and pharmacogenomic laboratory. WebJun 15, 2024 · Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis J.I. Silverberg et al. Localized Prostate Cancer — Then and Now O. Sartor Fifteen-Year Outcomes after Monitoring,...
Transplanting Hepatitis C Kidneys Into Negative Kidney …
WebJan 10, 2024 · January 10, 2024 The next stage of the THINKER project — THINKER-NEXT — is aiming to settle any lingering concerns that patients and centers might have about … WebThe goal of the THINKER-NEXT study is to make more kidneys available for transplant. THINKER-NEXT is a study that will provide HCV infected kidneys to people on the kidney … How can I learn more about THINKER-NEXT? Watch our educational videos to … Why should we use kidneys from HCV infected donors? Patients usually wait at … © 2024 CRCU University of Pennsylvania. All rights reserved. MODX is licensed … Principal Investigator: Raymond Chung, MD, FAASLD . Research Study Contact: Ian … unedited eyes wide shut
New England Journal of Medicine
WebPubMed WebJan 10, 2024 · The next stage of the THINKER project — THINKER-NEXT — is aiming to settle any lingering concerns that patients and centers might have about using kidneys from hepatitis C (HCV)-infected donors and transplanting them into HCV-negative recipients in need of a kidney transplant. ... The trial will take place over the next 5 years and will be ... WebThe HOPE Trial is an NIDDK-funded randomized clinical trial to evaluate approaches to reducing pain and opioid use among patients with chronic pain who are receiving maintenance hemodialysis for end-stage renal disease. Read more Risk Underlying Rural Areas Longitudinal (RURAL) Cohort Study Funding: NHLBI Investigator (s): Ramachandran, V thraud